← Back to All Filings

AngioDynamics CLO Buys $118K in Company Stock (ANGO)

Low SignificanceOctober 22, 2025 at 7:01:49 AM EDT

ANGIODYNAMICS INC

$ANGO4CIK: 0001275187

Subscribe to track ANGO

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

AngioDynamics CLO Buys $118K in Company Stock (ANGO)

Company: ANGIODYNAMICS INC (ANGO) Form: 4 | Filed: 2025-10-22 Significance: Low

Insider: Weiss Lawrence T Title: SVP, Chief Legal Officer | Relationship: Officer

Transaction: • Type: Buy • Shares: 10,000 • Price: $11.81 • Value: $118,100 • Owned After: 93,597

Key Insight: The SVP & Chief Legal Officer made an open-market purchase, a signal of confidence, though the transaction size is small relative to the company's market cap.

Market Context: This purchase increases the insider's direct holdings by approximately 12%.

Comprehensive Analysis

SEC Filing Analysis: ANGIODYNAMICS INC (ANGO)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: The SVP & Chief Legal Officer of AngioDynamics purchased 10,000 shares for $118,100, an open-market transaction signaling insider confidence.
  • Market Impact: The transaction is quantitatively small, representing less than 0.03% of market cap and shares outstanding, suggesting a minimal immediate market impact.

Company Information

FieldValue
CompanyANGIODYNAMICS INC
Ticker SymbolANGO
CIK0001275187
IndustrySurgical & Medical Instruments & Apparatus

Insider Information

FieldValue
NameWeiss Lawrence T
CIK0001930293
Title/PositionSVP, Chief Legal Officer
RelationshipOfficer

Transaction Details

FieldValue
Form Type4
Transaction Date2025-10-21
Transaction CodeP (Open Market Purchase)
Security TypeCommon Stock
Shares Involved10,000
Price Per Share$11.81
Total Value$118,100
Shares Owned After93,597
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$118,100
% of Market Cap0.024%
Shares Transacted10,000
% of Shares Outstanding0.024%
Post-Transaction Ownership93,597 shares (0.227% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: For AngioDynamics, with a market capitalization of $490 million, this $118,100 transaction is minor in scale.
  • Ownership Concentration: The purchase increases the insider's direct ownership from 83,597 to 93,597 shares, a 12% increase in their personal holding. However, their total ownership remains low at 0.227% of all outstanding shares.
  • Dilution Impact: Not applicable, as this was an open-market purchase, not an issuance of new equity.
  • Transaction Significance: Based on quantitative thresholds, the transaction is rated 'Low' significance as it falls well below the 0.1% of market cap and 0.1% of shares outstanding marks.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral to Slightly Positive
  • Reasoning: Open-market purchases by executives are inherently bullish signals. However, the small size of this transaction relative to the company's market cap and public float is unlikely to cause a significant price movement.

Volume & Sentiment

  • Expected Volume Impact: Minimal. The trade size is too small to materially affect trading volume.
  • Sentiment Indicator: Bullish. The action demonstrates an executive's belief in the company's value at the current price, which is a positive sentiment indicator for the market.

Investment Insights

Positive Market Indicators

  • An executive is using their own capital to increase their stake in the company.
  • The purchase was made on the open market, not as part of a compensation plan.

Risk Factors

  • The transaction size is not large enough to be considered a high-conviction buy.
  • The insider's total ownership stake remains a very small fraction of the company.

Key Takeaways

  1. Insider Confidence: The Chief Legal Officer's purchase is a classic signal of insider confidence in the company's prospects or current valuation.
  2. Low Materiality: From a market perspective, the trade's size is insignificant, representing just 0.024% of the company's market cap.
  3. Context is Key: While not a major financial event, it contributes to a pattern of positive insider sentiment if other executives are also buying.

Additional Context

Transaction Notes

  • Special Circumstances: The reported price of $11.81 is a weighted average. The shares were acquired in multiple transactions with prices ranging from $11.71 to $11.90.
  • Market Environment: This filing provides a data point on how a key insider views the company's stock value at this specific time.
Topics:#SECFiling#InsiderTrading#Form4#ANGO#AngioDynamics#InsiderBuy#StockMarket#Investing#MarketAnalysis

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.